Reporting Adverse Events in Gene Therapy Studies.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 141, doi. 10.2165/00063030-200014030-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2000 AND VI 14 AND IP 3
Results: 7
1
2
Hyperimmune Products in the Prevention and Therapy of Infectious Disease: A Report of a Hyperimmune Products Expert Advisory Panel.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 147, doi. 10.2165/00063030-200014030-00002
- By:
- Publication type:
- Article
3
Comparative Tolerability of Treatments for Juvenile Idiopathic Arthritis.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 159, doi. 10.2165/00063030-200014030-00003
- By:
- Publication type:
- Article
4
Cyclosporin as Baseline Immunosuppression in Solid Organ Transplantation.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 185, doi. 10.2165/00063030-200014030-00004
- By:
- Publication type:
- Article
5
I Tositumomab.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 195, doi. 10.2165/00063030-200014030-00005
- By:
- Publication type:
- Article
6
I Tositumomab: A Viewpoint by Wolfgang Kern.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 203
- By:
- Publication type:
- Article
7
I Tositumomab: A Viewpoint by Michael L. Grossbard.
- Published in:
- BioDrugs, 2000, v. 14, n. 3, p. 203
- By:
- Publication type:
- Article